[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google

Omnitrope (somatropin [rDNA origin]) Information

FDA approves Omnitrope (somatropin [rDNA origin]) for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone and for long-term replacement therapy in adults with growth hormone deficiency of either childhood or adult-onset etiology.

Back to Top     Back to Drug Index

PDF requires the free Adobe Acrobat Reader

Date created: May 30, 2006, updated June 21, 2006